Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Concentric AB publishes Annual Report for 2023

Concentric AB published today the Annual Report for 2023 on www.concentricab.com and is available in both Swedish and English. The Swedish Annual Report is also available in European Single Electronic Format (ESEF). Link to Annual Report 2023 https://www.concentricinvestors.com/_downloads/AGM-2024/Concentric_AR2023_ENG.pdf  Link to ESEF Report 2023 (in Swedish) https://www.concentricinvestors.com/_downloads/AGM-2024/Concentric_AR2023_SWE.zip 

Cereno Scientific publishes Annual Report for 2023

Cereno Scientific (Nasdaq First North: CRNO B), a pioneering biotech developing innovative treatments for common and rare cardiovascular disease, today published their Annual Report for 2023.Cereno Scientific’s Annual Report for 2023 is available on the Company’s website, both in Swedish and in English. The Annual General Meeting (AGM) will be held in Gothenburg, Sweden, on April 16, 2024. The notice and other documents related to the AGM are available on the Company's website. For further information, please contact: Henrik Westdahl, Director IR & Communications Email: henrik.

Valmet to deliver a Valmet DNA Automation System to Lostock Sustainable Energy Plant in Northwich, the United Kingdom

Valmet Oyj’s trade press release on March 26, 2024 at 9:30 a.m. EETValmet will deliver a comprehensive Valmet DNA Automation System to Lostock Sustainable Energy Plant (LSEP) currently under construction in Northwich, Cheshire, the United Kingdom. The order was placed by LSEP and Valmet will work closely with their delivery partners, Black & Veatch, an engineering, procurement and construction management contractor, and Babcock & Wilcox, a powertrain technology provider. The order was included in Valmet’s orders received of the fourth quarter 2023. The value of the order will not be

Notification to shareholders of NYAB Plc regarding the transfer of shares from the Finnish book-entry system to Sweden

NYAB PlcCOMPANY ANNOUNCEMENT26 March 2024 at 09:30 THIS ANNOUNCEMENT MAY NOT BE PUBLISHED OR DISTRIBUTED, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, SOUTH AFRICA, THE UNITED STATES OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION OR DISTRIBUTION WOULD VIOLATE APPLICABLE LAWS OR RULES OR WOULD REQUIRE ADDITIONAL DOCUMENTS TO BE COMPLETED OR REGISTERED OR REQUIRE ANY MEASURE TO BE UNDERTAKEN IN ADDITION TO THE REQUIREMENTS UNDER FINNISH AND SWEDISH LAW. FOR FURTHER INFORMATION, SEE “IMPORTANT NOTICE” BELOW.Notification to shareholders

Guidance 2024 - high growth expectations

COMPANY ANNOUNCEMENT NO. 94 Inside informationToday, LED iBond International A/S launch its revenue outlook for 2024 and predicted cash flow from operations. Martin Løbel, CEO of LED iBond international comments: In December 2023, LED iBond succeeded in raising DKK 10 million in new capital despite difficult financial markets to extend the company’s runway towards self-sustained operations, and I’m pleased with this trust from our shareholders. Despite the successful steps during 2023, the overall objective is still for us to demonstrate substantial revenue growth, and based on our

AcuCort's study to be published in an international scientific journal

AcuCort AB has been informed that an article regarding the company's survey study on treatment preferences among Swedish patients with acute allergic reactions will be published in the scientific journal World Allergy Organization Journal.AcuCort is working to increase awareness of the oral film Zeqmelit®, with a planned launch at pharmacies in the Nordic countries during the summer. The scientific journal World Allergy Organization Journal, targeting allergists, allergy patient associations, and other relevant groups, has announced that an article on AcuCort's survey study will be

Notice of the Annual General Meeting of Fastighets AB Balder (publ)

The shareholders of Fastighets AB Balder (publ), corporate identity no. 556525–6905, (the ”Company”) are hereby invited to attend the Annual General Meeting (AGM) to be held on Friday, May 3, 2024 at 4 p.m. CET, at The West Sweden Chamber of Commerce, Parkgatan 49, Gothenburg. Registration for the AGM begins at 3 pm.The English text is an unauthorized translation solely for convenience purposes. In case of inconsistencies between the Swedish and the English text, the Swedish text shall prevail. Right to participate in the Annual General Meeting Shareholders who wish to participate in

Invitation to presentation of Alligo’s Interim Report for the first quarter 2024

Alligo will publish its Interim Report for the first quarter on Thursday April 25, at 8:00 a.m. CEST. In conjunction with this, Alligo is pleased to issue this invitation to a webcast conference call in which CEO & President Clein Johansson Ullenvik and CFO Irene Wisenborn Bellander will present the report and answer any subsequent questions.The conference call and presentation are available on the web or by telephone in accordance with the details below. Questions can be asked via the webcast  (written) or by logging in to the conference call (

Balder’s nomination committee proposes election of new Chairman of the Board and Board member

The nomination committee of Fastighets AB Balder (publ) has completed its work ahead of the Annual General Meeting on 3 May 2024. The nomination committee proposes that Sten Dunér be elected as new Chairman of the Board and that Carin Kindbom be elected as new Board member. The nomination committee proposes that current Board members Fredrik Svensson, Anders Wennergren and Erik Selin be re-elected.Christina Rogestam, who has been Chairman of the Board of Directors for 18 years, has declined re-election. The nomination committee has proposed that the new Chairman should be Sten Dunér, who

Notice of Orkla's Annual General Meeting 2024

The Annual General Meeting of Orkla ASA will be held on Thursday, 18 April 2024 at 10:00 am (CEST).The meeting will be conducted as a digital meeting, with participation via Lumi AGM. The shareholders will be able to participate in the meeting, vote and ask questions from smartphones, tablets or desktop devices. For further information regarding attending the meeting digitally, please refer to the guide to be found at www.orkla.com. The deadline for notice of attendance, registration of advance votes and proxies is 16 April 2024 at 11:59 p.m. (CEST) as further described in the Notice.

Notice to Annual General Meeting in Probi AB (publ)

The shareholders of Probi AB (publ), reg. no. 556417-7540, are hereby officially convened to the Annual General Meeting (“AGM”) which will be held on 7 May 2024 at 3.00 p.m. at Elite Hotel, Ideon Gateway, Scheelevägen 27, Lund, Sweden. The Board of Directors has decided that shareholders shall be able to exercise their voting rights at the AGM also by postal voting in accordance with the provisions in Probi’s Articles of Association. Right to participate, notification of participation and postal votingA shareholder who wishes to attend the meeting room or who wishes to exercise its

Repurchases of shares during week 12, 2024

Between March 18 2024 and 22 March 2024 Attendo AB (LEI code 549300KEJDL2FNITUW65) (“Attendo”) has repurchased in total 157,942 own shares (ISIN: SE0007666110) as part of the repurchase program initiated by the Board.The repurchases form part of the repurchase program of a maximum of 16,138,659 own shares for a total maximum amount of SEK 110,000,000 that Attendo announced on 8 February 2024. The repurchase program, which runs between 9 February 2024 and 24 April 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated

Change of Auditor

26 March 2024 Quantum Blockchain Technologies Plc( “QBT” or “the Company”) Change of Auditor Quantum Blockchain Technologies plc (AIM: QBT) wishes to notify it has appointed A.C.T. Audit Limited as the Company’s auditor.   In accordance with section 519 of the Companies Act 2006, the previous auditor has deposited with the Company a statement confirming that there are no matters to be brought to the attention of the Company’s members or creditors.   For further information please contact:   Quantum Blockchain Technologies PlcFrancesco Gardin, CEO and Executive

Peab builds another building at Sörbyn Prison

Peab has been commissioned to build another building at the Sörbyn Prison south of Umeå. The customer is Specialfastigheter Sverige AB and the contract is worth SEK 104 million.The building - like the ones Peab has previously built within the same project - will be built according to “Miljöbyggnad Gold”. This entails carefully choosing materials that are sustainable both when produced and over time. “I really appreciate our good collaboration with Specialfastigheter and the close dialogue with the Prison and Probation Service. This leads to continuous improvements in processes and the

Repurchases of shares by Concentric AB during week 12, 2024

Between 18 March 2024 and 22 March 2024 Concentric AB (LEI code 5493002G9GMTKIP3PW19) (“Concentric”) has repurchased in total 13,558 own shares (ISIN: SE0003950864) as part of the repurchase program initiated by the Board. The repurchases form part of the repurchase program of a maximum of 3,519,172 own shares for a total maximum amount of SEK 150,000,000 that Concentric announced on 26 July 2023. The repurchase program, which runs between 31 July 2023 and 31 March 2024, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 and the Commission Delegated

SAS files monthly operating reports with U.S. court and announces certain financial information for the Group

SAS AB (“SAS” or the “Company”) and each of its subsidiaries that are subject to the voluntary chapter 11 process in the U.S. will shortly file monthly operating reports, containing certain financial information for the period of November 1, 2023 to February 29, 2024 with the U.S. Bankruptcy Court for the Southern District of New York (the “Court”). All SAS companies that are subject to the voluntary chapter 11 process are each required to file operating reports with the Court on a monthly basis. The financial information contained in the monthly operating reports includes items such as cash

Invitation to SCA’s Q1 2024 press conference April 26, 2024, 10:00 CET

The press conference, which will be held in connection with the publication of SCA's report for the first quarter 2024, can be followed on-site, via webcast or telephone.The interim report will be published on April 26, 2024, at approximately 08:00 CET. The subsequent webcast press conference will be held at 10:00 CET. Participation in the press conference can only take place digitally and by telephone. At the press conference, President and CEO Ulf Larsson and CFO Andreas Ewertz will present the report and answer questions. The press conference will be webcast live at www.sca.com. It

NCC signs asphalt contracts valued at over SEK 0.5bn in Norway

To date this year, NCC in Norway has signed nine asphalt contracts with the Norwegian Public Roads Administration and several regions in Norway. The contracts extend for one year and have a combined value of approximately SEK 540 million. Weather and traffic cause wear and tear on roads, so regular maintenance is important to keep roads safe for users. A report prepared by NCC shows that the accumulated maintenance debt in the Scandinavian road system amounts to approximately EUR 7.8bn and that the road network will deteriorate if nothing is done. As of January 1, 2024, a new

Transaction in Own Shares

    26 March 2024 Vesuvius plc Share Buyback Programme – Transactions in Own Securities   Vesuvius plc (the "Company") announces that it has purchased the following number of its Ordinary Shares of 10p each from Jefferies International Limited (the “Broker”), pursuant to the terms of its Share Buyback Programme announced on 4 December 2023:   +---------------------------------------------------------------+----------+|Date of purchase: |25/03/2024|+-------------------------------------------------------------

Implantica completes Human Factors Validation Study for RefluxStop™ as part of the US FDA Premarket Approval Process

Implantica AG (publ.), a medtech company at the forefront of bringing advanced technology into the body, announces completion of the Human Factors Validation Study with 16 US surgeons as part of the US FDA Premarket Approval (PMA) process for RefluxStop™.In March, 16 foregut surgeons in the United States (U.S.) participated in a Human Factors Validation Study of the RefluxStop™ procedure at Northwestern University’s Simulation Lab in Chicago. RefluxStop™ is an innovative new surgical procedure for the treatment of gastroesophageal reflux disease (GERD).   The goal of the study is to

NRC GROUP ASA – Listing of senior unsecured green bond issue

Reference is made to the stock announcement published on 13 October 2023 by NRC Group ASA regarding the successful completion of a 4-year senior unsecured green bond issue with an initial issue amount of NOK 400 million.  The bond issue is listed on the Oslo Stock Exchange as of today.  Attached is the listing prospectus. For further information, please contact: Ole Anton Gulsvik, CFO of NRC Group Mobile: +47 99 56 85 20

Athletic apparel brand lululemon expands in Bibliotekstan

Performance wear brand lululemon is expanding and opening a new store at Biblioteksgatan 9 in Bibliotekstan. The new store extends over approximately 400 square metres and will offer lululemon’s wide range of all gender apparel and accessories. lululemon’s new store is the most recent in a series of new store openings at street level in Vildmannen 7, meaning that the property is now fully leased.lululemon was founded in Vancouver, Canada, in 1998, and is present today in large parts of the world. The brand is famous for technical products, rooted in yoga and now expanded to include run,

Neogap secures Eurostars funding to develop T-cell activity analysis

The Swedish biotech company Neogap Therapeutics has received SEK 5 million from Eurostars in a collaboration project with the French biotech company Okomera. The funding aims to enhance the development of an analysis method for T-cell activity against the patient's tumour.Neogap is developing pTTL, personalised Tumour Trained Lymphocytes, a tailored cell therapy that utilises modified proteins, known as neoantigens, to activate the immune system specifically against cancer cells. The therapy is currently being assessed in phase I/II clinical trials for the treatment of colorectal cancer.

There are no items matching the current filter
There are no more items matching the current filter
Back to top